Efficacy of a Polyvalent Inactivated-virus Vaccine in Protecting Mice from Infection with Clinical Strains of Group B Coxsackieviruses

References

• Pallansch M A. Epidemiology of group B coxsackieviruses. Coxsackieviruses – a general update, M Bendinelli, H Friedman. Plenum Press, New York 1988; 399–416
   Google Scholar
• Kandolf R, Hofschneider P H. Viral hear disease. Springer Semin Immunopathol 1989; 11: 1–13
   PubMed Web of Science ®Google Scholar
• Bowles N E, Olsen E GJ, Richardson P J, Archard L C. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986; 1: 1120–1123
   PubMed Web of Science ®Google Scholar
• Christensen M L, Pachman L M, Schneiderman R, Patel D C, Friedman J M. Prevalence of coxsackie group B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 1986; 29: 1365–1370
   PubMed Web of Science ®Google Scholar
• Cudsworth A G, Gamble D R, White G BB, Lendrum R, Woodrow J C, Bloom A. Aetiology of jevenile-onset diabetes. A prospective study. Lancet 1977; 1: 385–388
   PubMedGoogle Scholar
• Frisk G, Friman G, Tuvemao T, Fohlman J, Diderholm H. Coxsackie B virus IgM in children at onset of type 1(insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia 1992; 35: 249–253
   PubMed Web of Science ®Google Scholar
• Yousef G E, Man G F, Smith D G, Bell E J, Murugesan V, McCartney R A, Mowbray J F. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet 1988; 1: 146–150
   PubMed Web of Science ®Google Scholar
• Moore M, Morens D M. Enteroviruses, including polioviruses. Textbook of Human Virology, PSG, Littleton, R B Belshe, Massachusetts 1984; 407–488
   Google Scholar
• Melnick J L. Enteroviruses. Viral Infections of Humans, Epidemiology and Control, A S Evans. Plenum, New York 1982; 187–251
   Google Scholar
• Melnick J L. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. Virology, B N Fields, Dm Knipe, R M Chanock, J L Melnick, B Roixman, R E Shope. Raven, New York 1985; 739–784
   Google Scholar
• Strikas R A, Anderson L J, Parker R A. Temporal and geographic patterns of isolates of nonpolio enteroviruses in the United States, 1970–1983. J Infect Dis 1986; 153: 346–51
   PubMed Web of Science ®Google Scholar
• Berlin L E. Diagnosis and etiology of aseptic meningitis in infants less than two years of age. J Infect Dis 1993; 168: 888–892
   PubMed Web of Science ®Google Scholar
• Kogon A, Spigland I, Frothingham T E. The virus watch program. A continuing surveillance of viral infections in metropolitan New York families. Am J Epidemiol 1969; 89: 51–65
   PubMed Web of Science ®Google Scholar
• Porres E R, Werthammer J, Moss N, Bernstein J M, Belshe R B. Fatal coxsackievirus B4 infection in a neonate. South Med J 1985; 78: 1254–1256
   PubMed Web of Science ®Google Scholar
• See D M, Tilles J G. Viral myocarditis. Rev Infect Dis 1991; 13: 951–956
   PubMedGoogle Scholar
• LaPorte R E, Tajima N. Prevalence of insulin-dependent diabetes. National Diabetes Data group, Diabetes in America. NIH publication no. 85–1468. US Dept. of Health and Human Services, V-1-8, Washington DC 1985
   Google Scholar
• Gun W J, Connell D B, Randall B. Epidemiology of chronic fatigue syndrome: The Center for Disease Control study. Ciba foundation Symposium 1993; 173: 83–93
   PubMedGoogle Scholar
• Fohlman J, Pauksen K, Morein B, Bjare U, Ilbäck N G, Friman G. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effective against experimental myocarditis. Scand J Infect Dis Suppl 1993; 88: 103–108
   PubMedGoogle Scholar
• See D M, Tilles J G. Treatment of coxsackivirus A9 myocarditis in mice with WIN 54954. Antimicrob Agents Chemother 1992; 36: 425–428
   PubMed Web of Science ®Google Scholar
• See D M, Tilles J G. WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus. Antimicrob Agents Chemother 1993; 37: 1593–1598
   PubMed Web of Science ®Google Scholar
• Zar J H. Biostatistical analysis. Prentice-Hall, Inc., Englewood Cliffs, NJ 1974
   Google Scholar
• Jenista J A, Powell K R, Menegus M A. Epidemiology of neonatal enterovirus infection. J Pediatr 1984; 104: 685–690
   PubMed Web of Science ®Google Scholar
• Abelmann W H. Myocarditis and dilated cardiomyopathy [editorial]. West J Med 1989; 150: 458–459
   PubMedGoogle Scholar
• Craighead J E. The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus. Prog Med Virol 1975; 19: 161–214
   PubMedGoogle Scholar
• Center for Disease Control. Poliomyelitis prevention: Enhanced-potency inactivated poliovirus vaccine – Supplementary statement. MMWR. 1987; 36: 795–798
   PubMedGoogle Scholar
• Notkins A L, Onodera T, Prabhakar B S. Virus induced autoimmunity. Concepts in Viral Pathogenesis, A L Notkins, M BA Oldstone. Springer-Verlag, New York 1984; 210–215
   Google Scholar
• Gerling I, Nejman C, Chatterjee N K. Effect of coxsackievirus B4 infection in mice on expression of 64,000-M autoantigen and glucose sensitivity of islets before development of hyperglycemia. Diabetes 1988; 37: 1419–1425
   PubMed Web of Science ®Google Scholar
• Kaufman D L, Erlander M G, Clare-Salzer M, Atkinson M A, Maclaren M K, Tobin A J. Autoimmunity in two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283–292
   PubMed Web of Science ®Google Scholar
• Prabhakar B S, Haspel M V, McClintock P R, Notkins A L. High frequency of antigenic variants among naturally occurring human Coxsackie B4 isolates identified by monoclonal antibodies. Nature 1982; 300: 374–376
   PubMed Web of Science ®Google Scholar
• Jerzabek Z, Zabicka J, John A, Howlett J, Dunn G, Wood D J. Application of monoclonal antibody panels in the virologic and epidemiologic review of poliomyelitis in Poland, 1981–1990. Bull World Health Organ 1992; 70: 327–333
   PubMed Web of Science ®Google Scholar
• Szopa T M, Ward T, Dronfield N D, Portwood N D, Taylor K W. Coxsackie B4 isolates with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia 1990; 33: 325–328
   PubMed Web of Science ®Google Scholar
• Yoon J W, Austin M, Onodera T, Notkins A L. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child diabetic ketoacidosis. N Engl J Med 1979; 300: 1173–1179
   PubMed Web of Science ®Google Scholar